Survival benefit in patients. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Cell Line, Tumor Cells, Cultured Lymph Nodes Esophagogastric Junction

Organisms4

Mice, Inbred C57BL Mice, Nude Mice, Knockout Mice, Inbred BALB C

Diseases47

Lung Neoplasms Neoplasm Recurrence, Local Liver Neoplasms Breast Neoplasms Adenocarcinoma Carcinoma, Non-Small-Cell Lung Neoplasm Metastasis Pancreatic Neoplasms Brain Neoplasms Colorectal Neoplasms Carcinoma, Hepatocellular Liver Failure Disease Progression Lymphatic Metastasis Glioblastoma Neoplasms Prostatic Neoplasms Stomach Neoplasms Recurrence Melanoma Glioma Myocardial Infarction Postoperative Complications Hepatorenal Syndrome Carcinoma, Squamous Cell Disease Models, Animal Kidney Failure, Chronic Ovarian Neoplasms Esophageal Neoplasms Kidney Neoplasms Sepsis Carcinoma Heart Failure Carcinoma, Renal Cell Neoplasm Invasiveness Out-of-Hospital Cardiac Arrest Bone Neoplasms Skin Neoplasms Multiple Myeloma Death, Sudden, Cardiac Colonic Neoplasms Head and Neck Neoplasms Gastrointestinal Neoplasms Small Cell Lung Carcinoma Liver Failure, Acute Carcinoma, Small Cell Chronic Disease

Chemicals and Drugs58

Antineoplastic Agents Fluorouracil Cisplatin Benzenesulfonates Doxorubicin Tumor Markers, Biological Radium Cyclophosphamide Antibodies, Monoclonal, Humanized Niacinamide Phenylurea Compounds Antimetabolites, Antineoplastic Antibodies, Monoclonal Dacarbazine Antineoplastic Agents, Alkylating Platinum Compounds Deoxycytidine Protein Kinase Inhibitors Taxoids Vindesine Vincristine Methotrexate Organoplatinum Compounds Vinblastine Quinazolines Prednisone Tamoxifen Leucovorin Antineoplastic Agents, Hormonal Angiogenesis Inhibitors Paclitaxel Adrenergic beta-Antagonists Receptor, Epidermal Growth Factor Etoposide Tissue Extracts Pyridines Melphalan Interferon-alpha Receptor, erbB-2 Carboplatin Lomustine Ifosfamide Bleomycin Camptothecin Cancer Vaccines Tegafur Recombinant Proteins Pyrimidines Receptors, Estrogen Benzamides Piperazines Pyrroles Prostate-Specific Antigen Antineoplastic Agents, Phytogenic Antibodies, Monoclonal, Murine-Derived Antibiotics, Antineoplastic DNA Modification Methylases Aromatase Inhibitors

Analytical, Diagnostic and Therapeutic Techniques and Equipment102

Survival Rate Survival Analysis Disease-Free Survival Treatment Outcome Kaplan-Meier Estimate Retrospective Studies Antineoplastic Combined Chemotherapy Protocols Proportional Hazards Models Chemotherapy, Adjuvant Combined Modality Therapy Follow-Up Studies Neoplasm Staging Prognosis Randomized Controlled Trials as Topic Multivariate Analysis Clinical Trials as Topic Radiotherapy, Adjuvant Patient Selection Risk Assessment Risk Factors Prospective Studies Cohort Studies Clinical Trials, Phase III as Topic Neoadjuvant Therapy Propensity Score Drug Administration Schedule Liver Transplantation Registries Chemoembolization, Therapeutic Predictive Value of Tests SEER Program Lymph Node Excision Immunohistochemistry Gastrectomy Palliative Care Severity of Illness Index Kidney Transplantation Hepatectomy Disease Models, Animal Remission Induction Clinical Trials, Phase II as Topic Decision Support Techniques Cause of Death Heart Transplantation Chemoradiotherapy Lung Transplantation Drug Therapy, Combination Transplantation, Homologous Life Expectancy Pneumonectomy Radiotherapy Dosage Chi-Square Distribution Immunotherapy Chemoradiotherapy, Adjuvant Radiotherapy Salvage Therapy Probability Reoperation Xenograft Model Antitumor Assays Defibrillators, Implantable Analysis of Variance Coronary Artery Bypass Maintenance Chemotherapy Myocardial Revascularization Meta-Analysis as Topic Mastectomy Resuscitation Treatment Failure Esophagectomy Endpoint Determination Incidence Pancreatectomy Hospital Mortality Risk Multicenter Studies as Topic Renal Dialysis Double-Blind Method Random Allocation Quality-Adjusted Life Years Regression Analysis Logistic Models Markov Chains Molecular Targeted Therapy Odds Ratio Statistics, Nonparametric Infusions, Intravenous Infusions, Intra-Arterial Angioplasty, Balloon, Coronary Transplantation, Autologous Hematopoietic Stem Cell Transplantation Stroke Volume Confidence Intervals Orchiectomy Tomography, X-Ray Computed Neoplasm Transplantation Bone Marrow Transplantation Actuarial Analysis Mortality Internal Mammary-Coronary Artery Anastomosis Thrombolytic Therapy Sensitivity and Specificity Length of Stay

Psychiatry and Psychology1

Decision Making

Phenomena and Processes18

Cell Survival Time Factors Graft Survival Apoptosis Signal Transduction Dose-Response Relationship, Drug Cell Proliferation Mutation Chi-Square Distribution Probability Graft Rejection Drug Resistance, Neoplasm Risk Markov Chains Odds Ratio Stroke Volume Gene Expression Regulation, Neoplastic Sensitivity and Specificity

Disciplines and Occupations5

Freshwater Biology Medical Oncology Immunohistochemistry Evidence-Based Medicine Outcome Assessment (Health Care)

Anthropology, Education, Sociology and Social Phenomena2

Survival Quality of Life

Humanities1

Quality of Life

Information Science11

Survival Rate Registries SEER Program Decision Support Techniques Cause of Death Life Expectancy Incidence Hospital Mortality Quality-Adjusted Life Years Databases, Factual Mortality

Named Groups3

Tissue Donors Survivors Living Donors

Health Care60

Survival Rate Survival Analysis Disease-Free Survival Treatment Outcome Kaplan-Meier Estimate Retrospective Studies Proportional Hazards Models Follow-Up Studies Randomized Controlled Trials as Topic Waiting Lists Multivariate Analysis Clinical Trials as Topic Patient Selection Risk Assessment Risk Factors Prospective Studies Cohort Studies Clinical Trials, Phase III as Topic Cost-Benefit Analysis Propensity Score Age Factors Registries Insurance Benefits Predictive Value of Tests Tissue and Organ Procurement SEER Program Palliative Care Severity of Illness Index Clinical Trials, Phase II as Topic Cause of Death Life Expectancy Chi-Square Distribution Probability Analysis of Variance Meta-Analysis as Topic Treatment Failure Sex Factors Incidence Hospital Mortality Risk Multicenter Studies as Topic Double-Blind Method Random Allocation Benchmarking Quality-Adjusted Life Years Regression Analysis Logistic Models Comorbidity Markov Chains Odds Ratio Statistics, Nonparametric Medicare Outcome Assessment (Health Care)Health Benefit Plans, Employee Confidence Intervals Practice Guidelines as Topic Actuarial Analysis Mortality Sensitivity and Specificity Length of Stay

Geographicals4

United States Great Britain Japan Canada

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Survival Rate Survival Analysis Cell Survival Disease-Free Survival Treatment Outcome Survival Kaplan-Meier Estimate Retrospective Studies Time Factors Antineoplastic Combined Chemotherapy Protocols Proportional Hazards Models Graft Survival Chemotherapy, Adjuvant Combined Modality Therapy Follow-Up Studies Neoplasm Staging Antineoplastic Agents Prognosis Randomized Controlled Trials as Topic Lung Neoplasms Waiting Lists Fluorouracil Multivariate Analysis Clinical Trials as Topic Neoplasm Recurrence, Local Liver Neoplasms Breast Neoplasms Radiotherapy, Adjuvant Patient Selection Adenocarcinoma Risk Assessment Risk Factors Prospective Studies Cohort Studies Cisplatin Carcinoma, Non-Small-Cell Lung Clinical Trials, Phase III as Topic Neoplasm Metastasis Freshwater Biology Pancreatic Neoplasms Neoadjuvant Therapy Brain Neoplasms Cost-Benefit Analysis Propensity Score United States Benzenesulfonates Age Factors Colorectal Neoplasms Carcinoma, Hepatocellular Drug Administration Schedule Liver Failure Disease Progression Liver Transplantation Doxorubicin Registries Tumor Markers, Biological Radium Chemoembolization, Therapeutic Apoptosis Cyclophosphamide Antibodies, Monoclonal, Humanized Niacinamide Lymphatic Metastasis Insurance Benefits Phenylurea Compounds Medical Oncology Predictive Value of Tests Tissue and Organ Procurement Glioblastoma SEER Program Tissue Donors Neoplasms Prostatic Neoplasms Antimetabolites, Antineoplastic Cell Line, Tumor Antibodies, Monoclonal Stomach Neoplasms Dacarbazine Quality of Life Lymph Node Excision Recurrence Melanoma Antineoplastic Agents, Alkylating Platinum Compounds Deoxycytidine Protein Kinase Inhibitors Glioma Signal Transduction Taxoids Immunohistochemistry Vindesine Myocardial Infarction Gastrectomy Vincristine Postoperative Complications Hepatorenal Syndrome Palliative Care Carcinoma, Squamous Cell Severity of Illness Index Kidney Transplantation

No FAQ available that match "survival benefit in patients"